This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3hy8
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:3hy8.png|left|200px]] | ||
| - | |||
{{STRUCTURE_3hy8| PDB=3hy8 | SCENE= }} | {{STRUCTURE_3hy8| PDB=3hy8 | SCENE= }} | ||
| - | |||
===Crystal Structure of Human Pyridoxine 5'-Phosphate Oxidase R229W Mutant=== | ===Crystal Structure of Human Pyridoxine 5'-Phosphate Oxidase R229W Mutant=== | ||
| + | {{ABSTRACT_PUBMED_19759001}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/PNPO_HUMAN PNPO_HUMAN]] Defects in PNPO are the cause of pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) [MIM:[http://omim.org/entry/610090 610090]]; also known as PNPO-related neonatal epileptic encephalopathy. The main feature of neonatal epileptic encephalopathy is the onset within hours of birth of a severe seizure disorder that does not respond to anticonvulsant drugs and can be fatal. Seizures can cease with the administration of PLP, being resistant to treatment with pyridoxine. | ||
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/PNPO_HUMAN PNPO_HUMAN]] Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP).<ref>PMID:12824491</ref> | ||
==About this Structure== | ==About this Structure== | ||
| Line 14: | Line 16: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:019759001</ref><references group="xtra"/> | + | <ref group="xtra">PMID:019759001</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Pyridoxal 5'-phosphate synthase]] | [[Category: Pyridoxal 5'-phosphate synthase]] | ||
Revision as of 09:16, 24 March 2013
Contents |
Crystal Structure of Human Pyridoxine 5'-Phosphate Oxidase R229W Mutant
Template:ABSTRACT PUBMED 19759001
Disease
[PNPO_HUMAN] Defects in PNPO are the cause of pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) [MIM:610090]; also known as PNPO-related neonatal epileptic encephalopathy. The main feature of neonatal epileptic encephalopathy is the onset within hours of birth of a severe seizure disorder that does not respond to anticonvulsant drugs and can be fatal. Seizures can cease with the administration of PLP, being resistant to treatment with pyridoxine.
Function
[PNPO_HUMAN] Catalyzes the oxidation of either pyridoxine 5'-phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal 5'-phosphate (PLP).[1]
About this Structure
3hy8 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Musayev FN, Di Salvo ML, Saavedra MA, Contestabile R, Ghatge MS, Haynes A, Schirch V, Safo MK. Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder. J Biol Chem. 2009 Nov 6;284(45):30949-56. Epub 2009 Sep 15. PMID:19759001 doi:10.1074/jbc.M109.038372
- ↑ Musayev FN, Di Salvo ML, Ko TP, Schirch V, Safo MK. Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase. Protein Sci. 2003 Jul;12(7):1455-63. PMID:12824491
Categories: Homo sapiens | Pyridoxal 5'-phosphate synthase | Musayev, F N. | Saavedra, M K. | Safo, M K. | Salvo, M L.Di. | Schirch, V. | Disease mutation | Epilepsy | Flavoprotein | Fmn | Fmn binding protein | Oxidase | Oxidoreductase | Phosphoprotein | Pyridoxal phosphate | Pyridoxine biosynthesis
